| ★ |  Eli Lilly Says Weight Loss Pill On Track for 2Q Launch in US | Bloomberg Television @markets | — | Estados Unidos | |
| 12 |  Novo Nordisk CEO on medicare coverage, new obesity pill, U.S. pricing pressure | CNBC Television @cnbctelevision | — | Estados Unidos | 86 |
| 13 |  Generic Ozempic to Upend Global Weight-Loss Drug Market | Bloomberg News @bloomberg-news | — | Estados Unidos | 86 |
| 15 |  Novo Sues Hims to Halt Obesity Drug Copycats | Bloomberg Businessweek Daily 2/09/2026 | Bloomberg Podcasts @bloombergpodcasts | — | Estados Unidos | 85 |
| 16 |  Novo Sues Hims to Halt Obesity Drug Copycats | Bloomberg Businessweek Daily 2/09/2026 | Bloomberg Television @markets | — | Estados Unidos | 85 |
| 7 |  Access expanding for experimental weight loss drug | | 144.2K | — | 87 |
| 4 |  New Weight Loss Drug Retatrutide Delivers Stunning Results | | 132.4K | — | 87 |
| 10 |  The Next Phase Of The Obesity Drug Race | | 115.3K | — | 86 |
| 1 |  What to know about the new weight loss pill approved by the FDA | | 47.5K | — | 89 |
| 5 |  Forget Injections. Now You Can Just Take Pills For Weight Loss | | 38.8K | — | 87 |
| 6 |  Why Eli Lilly is Winning the Weight Loss War | The Wall Street Journal @wsj | 27.4K | Estados Unidos | 87 |
| 8 |  FDA approves Eli Lilly weight loss pill | CBS Evening News @cbseveningnews | 25.3K | — | 87 |
| 2 |  FDA approves Eli Lilly's new weight loss pill Foundayo | | 11.0K | — | 88 |
| 20 |  Weight Loss Wars Intensify as Novo sues to keep copycats off shelves | Bloomberg Television @markets | 4.2K | Estados Unidos | 85 |
| 9 |  Novo Nordisk says Wegovy shows greater weight loss than Eli Lilly's rival pill | | 3.1K | Estados Unidos | 87 |
| 11 |  Novo CEO Sees 'Positive Growth on the Other Side of the Business' | Bloomberg Podcasts @bloombergpodcasts | 2.5K | Estados Unidos | 86 |
| 18 |  Bloomberg Money Minute | Bloomberg Podcasts @bloombergpodcasts | 2.1K | Estados Unidos | 85 |
| 14 |  Lilly's Foundayo weight loss pill clears heart safety bar in largest diabetes trial yet | | 1.5K | Estados Unidos | 86 |
| 19 |  Pepsi Reports; AstraZeneca and Levi Strauss Fall | Stock Movers | Bloomberg Podcasts @bloombergpodcasts | 720 | Estados Unidos | 85 |
| 3 |  FDA Approved $25 Weight Loss Drug | | 121 | Estados Unidos | 88 |
| 17 |  Lipoless MD 10 Review: 82% Regain Their Weight — Here's the Full Story (2026) | Savage Reviews @savagereviewsofficial | 100 | Estados Unidos | 85 |